Omeros (OMER) Receivables (2010 - 2026)
Omeros (OMER) reported Receivables of $12.1 million for Q1 2026, up 42.23% on a YoY basis from $8.5 million in Q1 2025, and up 3.92% sequentially from $11.7 million in Q4 2025.
Omeros (OMER) Receivables (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Receivables data on file, last reported at $12.1 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 42.23% year-over-year to $12.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.1 million (up 42.23% YoY), and the FY2025 full-year result was $11.7 million, up 36.65% from the prior year.
- Receivables climbed to $12.1 million in Q1 2026, from $11.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $213.5 million in Q4 2022 to a low of $6.7 million in Q3 2024.
- A 5-year average of $22.3 million and a median of $9.5 million in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables jumped 436.3% in 2022 and slumped 95.56% in 2023, its largest moves.
- Tracing OMER's Receivables over 5 years: stood at $213.5 million in 2022, then tumbled by 95.56% to $9.5 million in 2023, then retreated by 9.82% to $8.5 million in 2024, then surged by 36.65% to $11.7 million in 2025, then advanced by 3.92% to $12.1 million in 2026.
- Business Quant data shows OMER's Receivables at $12.1 million in Q1 2026, $11.7 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 12.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.12 Mn |
| Dec 31, 2025 | 11.67 Mn |
| Sep 30, 2025 | 7.77 Mn |
| Jun 30, 2025 | 7.34 Mn |
| Mar 31, 2025 | 8.52 Mn |
| Dec 31, 2024 | 8.54 Mn |
| Sep 30, 2024 | 6.69 Mn |
| Jun 30, 2024 | 9.35 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Dec 31, 2023 | 9.47 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 11.32 Mn |
| Mar 31, 2023 | 10.34 Mn |
| Dec 31, 2022 | 213.48 Mn |
| Sep 30, 2022 | 14.60 Mn |
| Jun 30, 2022 | 15.29 Mn |
| Mar 31, 2022 | 16.71 Mn |
| Dec 31, 2021 | 39.81 Mn |
| Sep 30, 2021 | 33.90 Mn |
| Jun 30, 2021 | 31.84 Mn |